Evidence map›Paper›PMID 36851631›Full record

ArticleViruses2023

Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal.

Binita Basukala, Sarah Rossi, Sally Bendiks, Natalia Gnatienko, Gregory Patts, Evgeny Krupitsky, Dmitry Lioznov, Kaku So-Armah, Manish Sagar, Christine Cheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Replacement Therapy with Blood Products in People Living with HIV.Tropical medicine and infectious disease · 2024
    Article
  5. HIV-1 latency reversal agent boosting is not limited by opioid use.medRxiv : the preprint server for health sciences · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Binita BasukalaDepartment of Biology, Boston University, Boston, MA 02215, USA.
Sarah RossiClinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Sally BendiksClinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Natalia GnatienkoClinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Gregory PattsBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA 02118, USA.
Evgeny KrupitskyLaboratory of Clinical Pharmacology of Addictions, Pavlov First St. Petersburg State Medical University, Saint-Petersburg 197022, Russia.
Dmitry LioznovLaboratory of Clinical Pharmacology of Addictions, Pavlov First St. Petersburg State Medical University, Saint-Petersburg 197022, Russia.
Kaku So-ArmahClinical Addiction Research and Education (CARE) Unit, Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Manish SagarDepartment of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Christine ChengDepartment of Biology, Boston University, Boston, MA 02215, USA.
Andrew J HendersonDepartment of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.ORCID 0000-0002-9299-5302
Boston University · USFirst Pavlov State Medical University of St. Petersburg · RU

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIVU01DA056006 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christine Cheng, DAVID J MOORE · 2022 to 2026
$7.9M
Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human BrainUM1DA051411 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHENG, CHRISTINE · 2020 to 2024
$5.1M
Persistent HIV-1 expression and microglia dysfunctionR01DA055488 · NIDA · BOSTON MEDICAL CENTER · PI GUMMULURU, SURYARAM, HENDERSON, ANDREW J · 2021 to 2025
$3.7M
Linking Russian Narcology and HIV Care to Enhance Treatment, Retention and Outcomes Part IIR01DA045547 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2017 to 2021
$3.7M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmissionR01AI172843 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2022 to 2025
$3.5M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Single nuclei transcriptomics of Alzheimer's brain diseaseR61DA047032 · NIDA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI CHENG, CHRISTINE, HENDERSON, ANDREW J · 2018 to 2020
$3.5M
Signals that establish and maintain HIV latencyR01AI138960 · NIAID · BOSTON MEDICAL CENTER · PI HENDERSON, ANDREW J · 2018 to 2022
$2.2M
Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomicsR33DA047032 · NIDA · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI CHENG, CHRISTINE, HENDERSON, ANDREW J · 2021 to 2022
$1.8M
HIV-1 mucosal transmission and persistenceK24AI145661 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2019 to 2023
$908k
NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24 AA020779NIAID NIH HHS K24 AI145661NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI138960NIAID NIH HHS R01 AI172843NIDA NIH HHS DA047032 R61/R33NIDA NIH HHS R01 DA045547NIDA NIH HHS R01 DA055488NIDA NIH HHS R01DA055488NIDA NIH HHS R33 DA047032NIDA NIH HHS R61 DA047032NIDA NIH HHS U01 DA056006NIDA NIH HHS UM1 DA051411
6 · The paper itself

Abstract

Of the 12 million people who inject drugs worldwide, 13% live with HIV. Whether opioid use impacts HIV pathogenesis and latency is an outstanding question. To gain insight into whether opioid use influences the proviral landscape and latent HIV reservoir, we performed intact proviral DNA assays (IPDA) on peripheral blood mononuclear cells (PBMCs) from antiretroviral therapy (ART)-suppressed people living with HIV (PWH) with or without current opioid use. No differences were observed between PWH with and without opioid use in the frequency of HIV intact and defective proviral genomes. To evaluate the latent reservoir, we activated PBMCs from ART-suppressed PWH with or without opioid use and assessed the induction of HIV RNA. PWH using opioids had diminished responses to ex vivo HIV reactivation, suggesting a smaller reversible reservoir of HIV-1 latently infected cells. However, in vitro studies using primary CD4+ T cells treated with morphine showed no effect of opioids on HIV-1 infection, replication or latency establishment. The discrepancy in our results from in vitro and clinical samples suggests that while opioids may not directly impact HIV replication, latency and reactivation in CD4+ T cells, opioid use may indirectly shape the HIV reservoir in vivo by modulating general immune functions.

Indexed as

HIV-1HIV InfectionsAnalgesics, OpioidHumansLeukocytes, MononuclearProvirusesVirus LatencyAnalgesics, OpioidHIV latencyHIV pathogenesisopioid use

Identifiers

PMID36851631
PMCPMC9961149
OpenAlexW4319027772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.